Q2N0S5 (Q2N0S5_9HIV1) Human immunodeficiency virus 1
Envelope glycoprotein gp160 UniProtKBInterProInteractive Modelling
860 aa; Sequence (Fasta)
It is possible new templates exist for this target since these models were created.
Available Structures
28 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 1×NAG; 2×NAG; 1×NAG; 7×NAG; 1×NAG; 1×NAG; 5×SO4; 9×NAG; 1×83G; | ||||
| Assess | ||||||
| Crystal Structure of the HIV-1 BG505 SOSIP.664 Env Trimer Ectodomain, Comprising Atomic-Level Defin… |
Heteromer | 3×NAG; 3×NAG; 24×NAG; 3×NAG; 3×NAG; 3×NAG; 3×NAG; 24×NAG; 30×SO4; | ||||
| Assess | ||||||
| Crystal Structure of HIV-1 BG505 SOSIP.664 Prefusion Env Trimer Bound to Small Molecule HIV-1 Entry… |
Heteromer | 1×NAG; 1×NAG; 1×NAG; 8×NAG; 1×NAG; 1×NAG; 1×NAG; 5×SO4; 8×NAG; 1×83J; | ||||
| Assess | ||||||
| Cryo-EM structure of BG24 Fabs with an inferred germline light chain and 10-1074 Fabs in complex wi… |
Heteromer | 3×NAG; 3×NAG; 3×NAG; 33×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of BG24 inferred germline Fabs with germline CDR3s and 10-1074 Fabs in complex wi… |
Heteromer | 18×NAG; 3×NAG; 2×NAG; 1×NAG; 15×NAG; 1×MAN; | ||||
| Assess | ||||||
| Cryo-EM structure of BG24 inferred germline Fabs with mature CDR3s and 10-1074 Fabs in complex with… |
Heteromer | 2×NAG; 2×NAG; 12×NAG; 2×MAN; 1×NAG; 1×NAG; 21×NAG; 4×MAN; | ||||
| Assess | ||||||
| Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 E… |
Heteromer Q2N0S7; | 9×NAG; 12×NAG; 15×NAG; 6×NAG; 3×NAG; 3×NAG; 3×NAG; 6×NAG; | ||||
| Assess | ||||||
| Glutaraldehyde-treated BG505 SOSIP.664 Env in complex with PGV04 Fab |
Heteromer Q2N0S7; | 6×NAG; 27×NAG; 3×NAG; 18×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 E… |
Heteromer Q2N0S7; | 18×NAG; 12×NAG; 6×NAG; 3×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; 3×MAN; | ||||
| Assess | ||||||
| cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with bNAbs EPTC112 and 3BNC117 |
Heteromer | 11×NAG; 2×NAG; 1×NAG; 24×NAG; | ||||
| Assess | ||||||
| Structure of HIV-1 BG505 SOSIP-HT1 in complex with one CD4 molecule |
Heteromer P01730; | 5×NAG; 2×NAG; 1×NAG; 1×NAG; 35×NAG; | ||||
| Assess | ||||||
| BG505 SOSIP in complex with sCD4, 17b, 8ANC195 |
Heteromer P01730; Q2N0S7; | 6×NAG; 3×NAG; 6×NAG; 18×NAG; | ||||
| Assess | ||||||
| Structure of HIV-1 BG505 SOSIP-HT2 in complex with two CD4 molecules (class I) |
Heteromer P01730; Q2N0S6; | 4×NAG; 4×NAG; 1×NAG; 7×NAG; | ||||
| Assess | ||||||
| Crystal structure of M4H2K1 Fab bound to HIV-1 BG505 gp120 core and to 17b Fab |
Heteromer | 3×NAG; 1×NAG; 1×NAG; 7×NAG; | ||||
| Assess | ||||||
| Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with … |
Heteromer Q2N0S6; | |||||
| Assess | ||||||
| Cryo-EM structure of CH235UCA bound to Man5-enriched CH505.N279K.G458Y.SOSIP.664 |
Heteromer M4M0W3; | 3×NAG; 6×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with complex… |
Heteromer M4M0W3; | 3×NAG; 6×NAG; 6×NAG; 3×NAG; 6×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.SOSIP.664 with high-ma… |
Heteromer M4M0W3; | 6×NAG; 3×NAG; 2×NAG; 13×NAG; 3×MAN; | ||||
| Assess | ||||||
| Cryo-EM structure of CH235.12 in complex with HIV-1 Env trimer CH505TF.N279K.G458Y.SOSIP.664 with h… |
Heteromer M4M0W3; | 3×NAG; 3×NAG; 3×NAG; 3×NAG; 12×NAG; | ||||
| Assess | ||||||
| XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex … |
Heteromer Q2N0S6; | 3×NAG; 3×NAG; 3×NAG; 9×NAG; 3×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 9×NAG; | ||||
| Assess | ||||||
| Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with … |
Heteromer Q2N0S6; | 6×NAG; 12×NAG; 9×NAG; 9×NAG; 6×NAG; 3×NAG; 3×NAG; 12×NAG; | ||||
| Assess | ||||||
| BG505 MD64 N332-GT2 SOSIP trimer in complex with germline-reverted BG18 fragment antigen binding |
Heteromer Q2N0S6; | 18×NAG; 3×NAG; 3×NAG; 18×NAG; | ||||
| Assess | ||||||
| Cryo-EM structure of BG505 SOSIP.664 HIV-1 Env trimer in complex with temsavir, 8ANC195, and 10-1074 |
Heteromer Q2N0S6; | 33×NAG; 3×NAG; 3×NAG; 3×NAG; 21×NAG; 3×83J; | ||||
| Assess | ||||||
| Cryo-EM structure of M1214_N1 Fab in complex with CH505 TF chimeric SOSIP.664 Env trimer |
Heteromer A0A0A7I3C6; | 15×NAG; 21×NAG; 6×NAG; 3×NAG; 3×NAG; 24×NAG; | ||||
| Assess | ||||||
| Crystal structure of a HIV-1 clade B tier-3 isolate H078.14 UFO-BG Env trimer in complex with broad… |
Heteromer A4ZPX1; Q2N0T3; | 3×NAG; 2×NAG; 2×NAG; 1×NAG; 1×NAG; 13×NAG; | ||||
| Assess | ||||||
| Structure of vaccine-elicited HIV-1 neutralizing antibody vFP16.02 in complex with HIV-1 fusion pep… |
Heteromer | 10×SO4; | ||||
| Assess | ||||||
| Vaccine-elicited HIV-1 neutralizing antibody vFP20.01 in complex with HIV-1 fusion peptide residue … |
Heteromer | 2×SO4; | ||||
| Assess | ||||||
| Structure of vaccine-elicited HIV-1 neutralizing antibody vFP7.04 in complex with HIV-1 fusion pept… |
Heteromer | |||||
| Assess | ||||||
2 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 8eu8.1.A | homo-3-mer | 0.66 | 78.35 | |||
| Assess | ||||||
| 7n6u.1.A | homo-3-mer | 0.58 | 1×NAG; | 76.46 | ||
| Assess | ||||||